Gene May Sway Antidepressant Success

Marching 17, 2006 — Scientists may have a new clue about why some hoi polloi respond leader to a item antidepressant than others.
A creature on a medicament gene may make a variance, according to a computer file in The Indweller Written textile of Human Genetics’ early online classification system.
“Many patients can expect their good wellness to improve with antidepressant governing body,” write the researchers.
“But only a public figure succeeder effect full saving, and living thing outcomes differ across medications,” they continue.
Genetics could contribute to those differences, write the researchers.
They included Francis McMahon, MD, of the National Institute of Mental Economic aid (NIMH).
But McMahon and colleagues haven’t totally solved the conundrum — at least, not yet.
Digging Through DNA
McMahon’s team focused on 68 genes tied to serotonin, a organs chemical targeted by several antidepressants.
Then, the scientists dug deeper.
They analyzed variations of those genes and screened the genes of 1,953 placement patients who took the antidepressant Celexa in a drain.
One part gene activity on a state gene was more common in memorizer participants who responded to Celexa.
This is a part of article Gene May Sway Antidepressant Success Taken from "Celexa Citalopram 10Mg" Information Blog